FDA Drug Application (010040) for RENOGRAFIN-76 by BRACCO

Back to FDA Applications sponsored by BRACCO

Application Number010040
Product Number001
FormINJECTABLE;INJECTION
Dosage66%;10%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameRENOGRAFIN-76
Active IngredientDIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Active IngredientCount
List of drugs with Active Ingredient DIATRIZOATE MEGLUMINE31
List of drugs with Active Ingredient DIATRIZOATE SODIUM21


Back to FDA Applications sponsored by BRACCO